Megachem (Thailand) Public Company Limited (MGT.BK)
Bangkok, TH
Megachem (Thailand) Public Company Limited primarily specializes in the distribution of advanced chemical products throughout Thailand. The company offers a wide array of chemical solutions that serve numerous industries and applications, including adhesives, cleaning products, construction, cosmetics, lubricants, paints, brake pads, oil and gas, paper manufacturing, food and beverage production, polyurethanes, inks, polymerization, plastics, pharmaceuticals, textiles, rubber, metal finishing, water treatment, and electronics. Beyond its core chemical offerings, Megachem (Thailand) also supplies construction materials, medical equipment for hospitals, and agricultural machinery. Established in 1992, the company maintains its headquarters in Bangkok, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.51% | -2.02% | +0.52% | -0.51% | +19.75% | +19.02% | +4.86% | -33.56% | -42.94% | +2.65% | +2.65% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+12.7% ★ Q1'26: +2.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+8.7% Q1'26: +9.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.3% Q1'26: +20.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.4% ★ Q1'26: +13.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.5% ★ Q1'26: +17.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +5.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.86× ★ Q1'26: 0.61× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
1.07B
est: 696.00M (+54.1%)
|
1.21B
est: 1.21B (+0.0%)
|
1.29B
1.29B – 1.29B
+7.0% YoY
|
1.36B
1.36B – 1.36B
+5.3% YoY
|
1.21B
1.21B – 1.21B
-11.3% YoY
|
1.29B
1.29B – 1.29B
+7.0% YoY
|
| EBITDA |
157.56M
est: 101.05M (+55.9%)
|
170.72M
est: 175.39M (-2.7%)
|
187.73M
187.73M – 187.73M
+7.0% YoY
|
197.75M
197.75M – 197.75M
+5.3% YoY
|
175.39M
175.39M – 175.39M
-11.3% YoY
|
187.73M
187.73M – 187.73M
+7.0% YoY
|
| EBIT |
137.02M
est: 88.67M (+54.5%)
|
149.95M
est: 153.90M (-2.6%)
|
164.73M
164.73M – 164.73M
+7.0% YoY
|
173.52M
173.52M – 173.52M
+5.3% YoY
|
153.90M
153.90M – 153.90M
-11.3% YoY
|
164.73M
164.73M – 164.73M
+7.0% YoY
|
| Net Income |
90.86M
est: 72.00M (+26.2%)
|
100.24M
est: 96.00M (+4.4%)
|
100.00M
100.00M – 100.00M
+4.2% YoY
|
108.00M
108.00M – 108.00M
+8.0% YoY
|
96.00M
96.00M – 96.00M
-11.1% YoY
|
100.00M
100.00M – 100.00M
+4.2% YoY
|
| SGA |
207.45M
est: 120.48M (+72.2%)
|
211.57M
est: 209.11M (+1.2%)
|
223.82M
223.82M – 223.82M
+7.0% YoY
|
235.77M
235.77M – 235.77M
+5.3% YoY
|
209.11M
209.11M – 209.11M
-11.3% YoY
|
223.82M
223.82M – 223.82M
+7.0% YoY
|
| EPS |
0.23
est: 0.18 (+27.8%)
|
0.25
est: 0.24 (+4.2%)
|
0.25
0.25 – 0.25
+4.2% YoY
|
0.27
0.27 – 0.27
+8.0% YoY
|
0.24
0.24 – 0.24
-11.1% YoY
|
0.25
0.25 – 0.25
+4.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jiraphan Rattanawong Bunmi | Operations Manager | — | female |
| Rattana Na Nakhon | Accounting Manager | — | female |
| Sumonta Uburanakaul | Chief Marketing Officer & Member of Management Board | — | female |
| Varit Inala | Chief Financial Officer & Executive Director | — | male |
| Vitthaya Inala | Chairman of Management Board, Chief Executive Officer & Vice Chairman | — | — |
| Wariya Inala | Human Resource Manager | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MGT.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
